What is The Concinnity?
The Concinnity Company specializes in clinical trial oversight software, with its flagship Cloud Concinnity® platform designed to support Data Safety Monitoring Boards (DSMB) and Data Monitoring Committees. This robust system centralizes critical data collection, analysis, and reporting functions, thereby enhancing collaboration among stakeholders and ensuring compliance throughout the clinical trial lifecycle. The software is tailored for a diverse clientele within the clinical trial ecosystem, aiming to streamline complex processes and elevate decision-making efficiency. By prioritizing patient safety, cost-effectiveness, and accelerating the time-to-market for new treatments, The Concinnity addresses the dynamic challenges inherent in modern clinical research.
How much funding has The Concinnity raised?
The Concinnity has raised a total of $329K across 2 funding rounds:
Debt
$150K
Debt
$179K
Debt (2020): $150K with participation from PPP
Debt (2021): $179K led by PPP
What's next for The Concinnity?
As The Concinnity navigates a large-scale, late-stage funding environment, the recent strategic investment signals a pivotal moment for the company. This capital infusion is likely to be directed towards scaling operations, expanding its market reach, and potentially enhancing its technological capabilities. The focus on clinical trial oversight software positions The Concinnity to capitalize on the growing demand for efficient and compliant research processes, particularly as the pharmaceutical and biotechnology sectors continue to invest heavily in drug development. Future growth may involve strategic partnerships or further product development to maintain a competitive edge in this specialized market.
See full The Concinnity company page
